2976 - 3000 of 7916 Results
Title
Year
-
OPENTitle: Accelerating Medicines Partnership: Parkinson's Disease. Genetic ResourceJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1795End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28549Best OA location URL: https://doi.org/10.1002/mds.28549Citation Count: 72
-
RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 5
-
OPENTitle: NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abf7114Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104867Citation Count: 13
-
RESTRICTEDTitle: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2144End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28631Citation Count: 53
-
RESTRICTEDTitle: Dopamine Receptors in Parkinson's Disease: A Meta‐Analysis of Imaging StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1781End Page: 1791Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28632Citation Count: 43
-
OPENTitle: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 787End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00847-6Best OA location URL: https://europepmc.org/articles/pmc8459648?pdf=renderCitation Count: 98
-
RESTRICTEDTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298526/file/Manuscript.pdfCitation Count: 13
-
OPENTitle: On the Road from Phenotypic Plasticity to Stem Cell TherapyJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 41Issue #: 25Start Page: 5331End Page: 5337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1523/jneurosci.0340-21.2021Best OA location URL: https://www.jneurosci.org/content/jneuro/41/25/5331.full.pdfCitation Count: 0
-
OPENTitle: Parkinson’s Disease Recognition Using SPECT Image and Interpretable AI: A TutorialJournal Name: IEEE Sensors JournalPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 21Issue #: 20Start Page: 22304End Page: 22316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/jsen.2021.3077949Best OA location URL: https://arxiv.org/pdf/1908.11199Citation Count: 21
-
RESTRICTEDTitle: The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and PreventionJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 9Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000752844.66769.73Citation Count: 0
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
-
OPENTitle: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1959End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28614Best OA location URL: https://doi.org/10.1002/mds.28614Citation Count: 12
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau2021OPENTitle: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202114022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202114022Citation Count: 108
-
RESTRICTEDTitle: Effect of gender in the onset and progression of Parkinson's diseaseJournal Name: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/ner49283.2021.9441293Citation Count: 0
- Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease2021RESTRICTEDTitle: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1964End Page: 1967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28630Citation Count: 4
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 25
-
RESTRICTEDTitle: Investigating Cognitive Global Coordination in normal and autistic children using virtual reality environments – An EEG StudyJournal Name: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/ner49283.2021.9441259Citation Count: 1
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://europepmc.org/articles/pmc8453505?pdf=renderCitation Count: 18
-
OPENTitle: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 76End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26094Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26094Citation Count: 36
-
RESTRICTEDTitle: Ischemic Events After Intracerebral HemorrhageJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 795End Page: 795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772Citation Count: 3
-
RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
OPENTitle: Alzheimer's Disease Alters Oligodendrocytic Glycolytic and Ketolytic Gene ExpressionJournal Name: The FASEB JournalPublisher: WileyVol: 35Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2021.35.s1.02461Best OA location URL: https://digitalcommons.wustl.edu/context/oa_4/article/3325/viewcontent/Alzheimer_s___Dementia___2021___Saito___Alzheimer_s_disease_alters_oligodendrocytic_glycolytic_and_ketolytic_gene.pdfCitation Count: 1
- Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations2021RESTRICTEDTitle: Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel RecommendationsJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 1589End Page: 1597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s310605Best OA location URL: https://www.dovepress.com/getfile.php?fileID=69709Citation Count: 13
-
RESTRICTEDTitle: Biomedical Research Must Change — But a Shift Toward Human-specific Research Methods Is Only Part of What Is NeededJournal Name: Alternatives to Laboratory AnimalsPublisher: SAGE PublicationsVol: 49Issue #: 3Start Page: 69End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/02611929211030417Citation Count: 5
-
OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: http://www.cell.com/article/S1525001621002495/pdfCitation Count: 33